AQB - アクアバウンティ・テクノロジ― (AquaBounty Technologies Inc.) アクアバウンティ・テクノロジ―

 AQBのチャート


 AQBの企業情報

symbol AQB
会社名 AquaBounty Technologies Inc (アクアバウンティ・テクノロジ―)
分野(sector)   
産業(industry)   
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 AquaBounty Technologies Inc. is a biotechnology company engaged in research development and commercialization of the commercial viability of a group of proteins antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS) which can be grown in contained land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company's subsidiaries include AquaBounty Canada Inc. which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company's technologies; AquaBounty Panama S. de R.L.; AquaBounty Farms Inc. and AquaBounty Brasil Participacoes Ltda. which conducts commercial trials of the Company's AquAdvantage Salmon.   アクアバウンティ・テクノロジ―は米国のバイオテクノロジ―企業。サケの遺伝子組み換え技術「アクアドバンテ―ジ」による養殖サケの生産に従事する。また、サケの成長期間を短縮し生産性を向上させる技術の開発に取り組む。同社の「アクアドバンテ―ジ・サ―モン」は米国食品医薬品局(FDA)の認可を受けている。本社所在地はマサチュ―セッツ州メイナ―ド。   AquaBounty Technologies, Inc. is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. The Company's objective is to ensure the availability of high-quality seafood to meet global consumer demand, while addressing critical production constraints in the most popular farmed species. The Company's AquAdvantage fish program is based upon a single, specific molecular modification in fish that results in more rapid growth in early development. With aquaculture facilities located in Prince Edward Island, Canada, and Indiana, USA, AquaBounty is raising its disease-free, antibiotic-free salmon in land-based recirculating aquaculture systems, offering a reduced carbon footprint and no risk of pollution of marine ecosystems as compared to traditional sea-cage farming.
本社所在地 Two Mill_Main Place Suite 395 Maynard MA 01754 USA
代表者氏名 Ronald L. Stotish Ronald L. Stotish
代表者役職名 President Chief Executive Officer Executive Director
電話番号 +1 978-648-6000
設立年月日 33573
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 37人
url www.aquabounty.com
nasdaq_url https://www.nasdaq.com/symbol/aqb
adr_tso
EBITDA EBITDA(百万ドル) -9.95695
終値(lastsale) 3.09
時価総額(marketcap) 39701481.84
時価総額 時価総額(百万ドル) 39.18755
売上高 売上高(百万ドル) 0.06700
企業価値(EV) 企業価値(EV)(百万ドル) 38.64687
当期純利益 当期純利益(百万ドル) -10.34041
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Aquabounty Technologies Inc revenues increased 26% to $67K. Net loss increased 26% to $5.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects General and administrative increase of 55% to $3.2M (expense) Research and development increase of 12% to $1.9M (expense) Other Income (expense).

 AQBのテクニカル分析


 AQBのニュース

   AquaBounty Technologies Inc Shares Approach 52-Week Low - Market Mover  2022/01/08 02:29:23 Kwhen Finance
AquaBounty Technologies Inc (AQB) shares closed today at 1.0% above its 52 week low of $2.01, giving the company a market cap of $145M. The stock is currently down 2.4% year-to-date, down 75.6% over the past 12 months, and down 91.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 13.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -51.4% The company's stock price performance over the past 12 months lags the peer average by 44.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   AquaBounty Technologies to Present at the H.C. Wainwright BioConnect Conference  2022/01/06 13:31:00 Benzinga
MAYNARD, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB ) ("AquaBounty" or the "Company"), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that management will participate in the H.C. Wainwright BioConnect Conference taking place on January 10-13, 2022. Sylvia Wulf, Chief Executive Officer of AquaBounty, is scheduled to host a virtual presentation at the H.C. Wainwright BioConnect Conference as follows: H.C. Wainwright BioConnect Conference Date: Monday, January 10, 2022 Recorded Presentation Available After 7:00 a.m. Eastern time Webcast: https://journey.ct.events/view/48f54ac3-5739-41c5-8c77-d812c57614bb The recorded presentation will remain accessible at the webcast link above through April 10, 2022. For more information, please contact your H.C. Wainwright representative. About AquaBounty AquaBounty Technologies, Inc. (NASDAQ: AQB ) is a leader in aquaculture leveraging decades of technology expertise to deliver game changing solutions that solve global problems, while improving efficiency, sustainability and profitability.
   AquaBounty Technologies Inc Shares Approach 52-Week Low - Market Mover  2021/12/30 01:10:11 Kwhen Finance
AquaBounty Technologies Inc (AQB) shares closed today at 1.0% above its 52 week low of $2.09, giving the company a market cap of $149M. The stock is currently down 75.9% year-to-date, down 77.3% over the past 12 months, and down 91.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 41.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 96.2% The company's stock price performance over the past 12 months lags the peer average by 85.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   -$0.08 Earnings Per Share Expected for AquaBounty Technologies, Inc. (NASDAQ:AQB) This Quarter  2021/12/17 20:46:42 Dakota Financial News
Analysts forecast that AquaBounty Technologies, Inc. (NASDAQ:AQB) will announce ($0.08) earnings per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for AquaBounty Technologies earnings. The highest EPS estimate is ($0.06) and the lowest is ($0.10). AquaBounty Technologies posted earnings of ($0.14) per share in the same quarter last []
   Brokerages Expect AquaBounty Technologies, Inc. (NASDAQ:AQB) Will Announce Quarterly Sales of $960,000.00  2021/12/17 20:46:42 Transcript Daily
Equities research analysts expect AquaBounty Technologies, Inc. (NASDAQ:AQB) to report sales of $960,000.00 for the current quarter, according to Zacks. Three analysts have provided estimates for AquaBounty Technologies earnings, with the lowest sales estimate coming in at $490,000.00 and the highest estimate coming in at $1.40 million. AquaBounty Technologies reported sales of $50,000.00 during the []
   AquaBounty Technologies Consensus Indicates Potential 155.8% Upside  2021/09/27 09:37:05 DirectorsTalk
AquaBounty Technologies with ticker code (AQB) have now 2 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 15 and 7 with the average target price sitting at 11. With the stocks previous close at 4.3 this now indicates there is a potential upside of 155.8%. The day 50 moving average is 4.46 and the 200 moving average now moves to 5.44. The market cap for the company is $292m. Company Website: /> [stock_market_widget type="chart" symbol="AQB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] AquaBounty Technologies, a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms and changed its name to AquaBounty Technologies in June 2004.
   AquaBounty Technologies Consensus Indicates Potential 163.2% Upside  2021/09/20 11:35:19 DirectorsTalk
AquaBounty Technologies found using ticker (AQB) now have 2 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 15 and 7 calculating the mean target price we have 11. Given that the stocks previous close was at 4.18 this now indicates there is a potential upside of 163.2%. The day 50 moving average is 4.56 while the 200 day moving average is 5.53. The market cap for the company is $313m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="AQB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] AquaBounty Technologies, a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms and changed its name to AquaBounty Technologies in June 2004.
   AQUABOUNTY TECHNOLOGIES TO PRESENT AT UPCOMING INVESTOR CONFERENCES  2021/09/14 04:00:18 Fish Focus
AquaBounty Technologies to present at upcoming Investor Conferences in September. AquaBounty Technologies, Inc. (Nasdaq: AQB) (AquaBounty or the Company), a land-based aquaculture company utilising technology to enhance productivity and sustainability, will participate in the following investor conferences during the month of September 2021: H.C. Wainwright Global Investment Conference on September 13-14, the Lake Street Best []
   AquaBounty Technologies to Present at Upcoming Investor Conferences in September  2021/09/09 12:30:00 Intrado Digital Media
MAYNARD, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (AquaBounty or the Company), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, will participate in the following investor conferences during the month of September 2021: H.C. Wainwright Global Investment Conference on September 13-14, the Lake Street Best Ideas Conference on September 14-15, and the Bank of America Future Fish Event on September 28.
   AquaBounty Technologies EPS in-line  2021/08/04 12:38:41 Seeking Alpha
   AquaBounty Technologies Consensus Indicates Potential 155.8% Upside  2021/09/27 09:37:05 DirectorsTalk
AquaBounty Technologies with ticker code (AQB) have now 2 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 15 and 7 with the average target price sitting at 11. With the stocks previous close at 4.3 this now indicates there is a potential upside of 155.8%. The day 50 moving average is 4.46 and the 200 moving average now moves to 5.44. The market cap for the company is $292m. Company Website: /> [stock_market_widget type="chart" symbol="AQB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] AquaBounty Technologies, a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms and changed its name to AquaBounty Technologies in June 2004.
   AquaBounty Technologies Consensus Indicates Potential 163.2% Upside  2021/09/20 11:35:19 DirectorsTalk
AquaBounty Technologies found using ticker (AQB) now have 2 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 15 and 7 calculating the mean target price we have 11. Given that the stocks previous close was at 4.18 this now indicates there is a potential upside of 163.2%. The day 50 moving average is 4.56 while the 200 day moving average is 5.53. The market cap for the company is $313m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="AQB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] AquaBounty Technologies, a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms and changed its name to AquaBounty Technologies in June 2004.
   AQUABOUNTY TECHNOLOGIES TO PRESENT AT UPCOMING INVESTOR CONFERENCES  2021/09/14 04:00:18 Fish Focus
AquaBounty Technologies to present at upcoming Investor Conferences in September. AquaBounty Technologies, Inc. (Nasdaq: AQB) (AquaBounty or the Company), a land-based aquaculture company utilising technology to enhance productivity and sustainability, will participate in the following investor conferences during the month of September 2021: H.C. Wainwright Global Investment Conference on September 13-14, the Lake Street Best []
   AquaBounty Technologies to Present at Upcoming Investor Conferences in September  2021/09/09 12:30:00 Intrado Digital Media
MAYNARD, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (AquaBounty or the Company), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, will participate in the following investor conferences during the month of September 2021: H.C. Wainwright Global Investment Conference on September 13-14, the Lake Street Best Ideas Conference on September 14-15, and the Bank of America Future Fish Event on September 28.
   AquaBounty Technologies EPS in-line  2021/08/04 12:38:41 Seeking Alpha

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アクアバウンティ・テクノロジ― AQB AquaBounty Technologies Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)